Fluvoxamine for the treatment of COVID-19

Lancet Glob Health. 2022 Mar;10(3):e331. doi: 10.1016/S2214-109X(21)00592-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment*
  • Fluvoxamine* / therapeutic use
  • Humans
  • SARS-CoV-2

Substances

  • Fluvoxamine